Menu

Recent Interviews

Humphrey Hale, CEO, Managing Geologist, Carnavale Resources Ltd.

Humphrey Hale
CEO, Managing Geologist | Carnavale Resources Ltd.
Level 2, Suite 9 389 Oxford Street, WA 6016 Mount Hawthorn (AUS)

info@carnavaleresources.com

Interview Carnavale Resources: Good cards for long-term success


Bill Guy, Chairman, Theta Gold Mines Limited

Bill Guy
Chairman | Theta Gold Mines Limited
Level 35 (ServCorp), Intl Tower One 100 Barangaroo Ave, 2000 NSW Australia (AUS)

info@thetagoldmines.com

+61 2 8046 7584

Interview Theta Gold Mines: This team has already brought 20 mines into production


David Mason, Managing Director, CEO, NewPeak Metals Ltd.

David Mason
Managing Director, CEO | NewPeak Metals Ltd.
Level 27, 111 Eagle Street, QLD 4000 Brisbane (AU)

info@newpeak.com.au

+61 7 3303 0650

Interview New Peak Metals: Many chances for great success


20. May 2021 | 07:55 CET

Grenke, TUI, RYU: Success with comeback stocks

  • Investments
Photo credits: pixabay.com

When companies are punished by the market, it usually leads to negative exaggerations. When it became clear after the outbreak of the pandemic that tourism was in the doldrums, investors even cautiously priced in bankruptcy for travel and tourism company TUI. When Grenke was confronted with accusations about opaque balance sheets, the share price also plummeted. We look at three shares to see how the market can continue after such price corrections and whether they offer opportunities.

time to read: 3 minutes by Nico Popp


 

Author

Nico Popp

At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

About the author


Grenke: Here is what happens after the scandal

Grenke is a success story as a provider of financing services for leasing. The Company from Baden-Baden has been growing for years. But when reports of possible balance sheet falsification were launched a few months ago, the stock took a nosedive. Since then, the share price has not fully recovered. Still, Grenke itself cannot be blamed. The Company quickly turned itself in and hosted conference calls, hired independent auditors, and reorganized to shed more light on subsidiary companies and other associates. Most recently, thanks to an unqualified opinion from the auditors at KPMG, the Company was able to break free - the share price rose by around 20% and is currently trading around EUR 38. Before the accusations, the share price had reached EUR 55.

As long as the critics around the British investor Fraser Perring do not follow up, the scandal could be over for Grenke. And the share price? It could develop further potential. Important resistances on the way up lurk between EUR 40 and EUR 41. If the share price manages to rise above this level in the next few days, it could generate additional momentum. However, how much confidence the scandal has destroyed will only become apparent in a few months. That is, if the share price is unable to return to the level it was at before the accusations.

TUI: Is the travel boom falling apart?

The TUI share is also a comeback story. Still at the bottom a year ago, the share has since put a return of almost 150% on the floor. Thanks to the intervention of the German government, TUI's bankruptcy is off the table. As vaccination success is also increasing in Europe, TUI shareholders are justifiably hopeful of a good summer season. But how much of this success is already priced in? The discussion surrounding digital proof of vaccination in Germany shows that the old freedom is by no means as self-evident as some investors brashly assume.

In Germany, unlike in Sweden, for example, vaccinations have not been digitally recorded. Millions of people will have to go back in early summer with their little yellow vaccination card - and register their vaccinations digitally. As if this process were not absurd enough, people in Germany are also arguing about its proper form. Nor has a suitable app yet been commissioned. As German Health Minister Jens Spahn has already indicated, federal government apps that handle sensitive data must be planned with extra care. It should be known in the 15th month of the pandemic what German diligence can do. Vacations are not yet safe. Many travelers could give up in exasperation and travel spontaneously. For TUI, that carries the risk of negative surprises.

RYU: "Get up when you are down."

Shareholders of Canadian fashion and lifestyle provider RYU also received a negative surprise. Just recently, the Company, which aims to achieve sales of CAD 100 million by 2025 at the latest, canceled its growth financing in the form of a convertible bond. The reason: poor market conditions. The share then crashed and is trading around EUR 0.05 in Germany, which corresponds to a market capitalization of about EUR 9 million. RYU stands for "Respect Your Universe" and impresses with sporty yet fashionable clothing and accessories. Anyone who wants to be casual and stylish at the same time between home office, gym and a meeting with friends can take a closer look at their fashion. At the end of last year, numerous products in RYU's stores were sold out. The brand is well received in the US and Canada.

RYU is constantly breaking new ground, especially when it comes to marketing. The Company has hired an agency to provide product placements in series and films. Since RYU's products have a high recognition value due to their simplicity, the strategy could work. RYU is also involved in the sponsorship of athletes and other influencers. CEO Cesare Fazari has set his Company the goal of growing positively by the end of the year. In the medium term, expansion into Europe could also be on the cards. RYU's stock is currently down; however, both RYU's brand and products are good. Long-term thinking shareholders who are used to managing risks via position size may take a closer look at the stock. Starting from the current level, eruptive breakouts are possible at any time.


Author

Nico Popp

At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

About the author



Conflict of interest & risk note

In accordance with §34b WpHG we would like to point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH may hold long or short positions in the aforementioned companies and that there may therefore be a conflict of interest. Apaton Finance GmbH may have a paid contractual relationship with the company, which is reported on in the context of the Apaton Finance GmbH Internet offer as well as in the social media, on partner sites or in e-mail messages. Further details can be found in our Conflict of Interest & Risk Disclosure.


Related comments:

18. June 2021 | 15:10 CET | by Carsten Mainitz

MorphoSys, Biogen, Sierra Growth - What is next?

  • Investments

Pharmaceutical stocks are a bit like that: Giants like Johnson & Johnson or Novartis have an extensive product portfolio and can cushion failures of individual products quite well. It is often a matter of life and death for smaller, specialized companies with every development. Just yesterday, this could be observed in the CureVac share after its Corona vaccine candidate only achieved an efficacy of 47% in the clinical 2b/3 phase. Within a very short time, it disintegrated the stock price. Meanwhile, biotech pioneer Biogen surprised with an unjustified share price rally, which, however, could come to an abrupt end after a new setback. The situation is different for MorphoSys. Its planned acquisition of Constellation Pharmaceuticals initially weighed heavily on the share price, but it holds exciting potential. And the Canadian mining Company Sierra Growth is operating in a completely different environment; however, it has a top opportunity to offer in the current inflationary environment and should not go unmentioned.

Read

18. June 2021 | 09:56 CET | by Nico Popp

Adler Modemärkte, Steinhoff, Osino Resources: Which penny stocks have substance?

  • Investments

Penny stocks often have something disreputable about them - at least in Germany. As soon as a share is quoted at less than EUR 1 in Germany, it is considered to be at risk of insolvency. The reason for this is that the minimum nominal value of German stock corporations is EUR 1. Abroad, however, things are quite different: In Australia, it is not uncommon for shares to trade even below one cent. For investors who are used to this, it is anything but disreputable. In concrete terms, it all depends on the companies themselves anyway. We profile three companies that are either penny stocks or were, not long ago.

Read

17. June 2021 | 13:52 CET | by Nico Popp

Daimler, Mineworx Technologies, BASF: Investing in the mobility revolution

  • Investments

The world keeps spinning - faster and faster, it feels. New technology is causing certain industries to rethink. Electromobility is one such catalyst: mining companies and companies from the chemical industry and other suppliers must prepare themselves because soon, most cars will run on batteries. There are great opportunities here - for carmakers who are on their toes and for resourceful experts in the field of recycling.

Read